ChiCTR2400091075 版本V1.0 版本创建时间2024/10/21 08:53:26 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400091075 

最近更新日期:

Date of Last Refreshed on:

2024-10-21 08:53:17 

注册时间:

Date of Registration:

2024-10-21 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

三叉神经痛球囊压迫术治疗疗效及复发危险因素分析

Public title:

Analysis of the Efficacy and Risk Factors for Recurrence of Trigeminal Neuralgia Treated by Balloon Compression

注册题目简写:

English Acronym:

研究课题的正式科学名称:

三叉神经痛球囊压迫术治疗疗效及复发危险因素分析

Scientific title:

Analysis of the Efficacy and Risk Factors for Recurrence of Trigeminal Neuralgia Treated by Balloon Compression

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

冯富媛 

研究负责人:

傅佳 

Applicant:

Fuyuan Feng 

Study leader:

Jia Fu 

申请注册联系人电话:

Applicant telephone:

+86 135 4026 7026

研究负责人电话:

Study leader's telephone:

+86 187 1579 6246

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

fyy1031172678@163.com

研究负责人电子邮件:

Study leader's E-mail:

372482447@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

四川省泸州市西南医科大学城北校区

研究负责人通讯地址:

四川省泸州市西南医科大学附属医院

Applicant address:

Southwest Medical University, North Campus, Luzhou City, Sichuan Province

Study leader's address:

Southwest Medical University Affiliated Hospital in Luzhou, Sichuan Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

西南医科大学

Applicant's institution:

Southwest Medical University

研究负责人所在单位:

西南医科大学附属医院

Affiliation of the Leader:

Southwest Medical University Affiliated Hospital

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

KY2024376

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

西南医科大学附属医院临床试验伦理委员会

Name of the ethic committee:

Ethics Committee of Clinical Trials of Southwest Medical University Affiliated Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2024-09-30 00:00:00

伦理委员会联系人:

张增瑞

Contact Name of the ethic committee:

Zengrui Zhang

伦理委员会联系地址:

泸州市太平街25号

Contact Address of the ethic committee:

25 Taiping Street, Luzhou City

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 830 316 5273

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

西南医科大学附属医院

Primary sponsor:

Southwest Medical University Affiliated Hospital

研究实施负责(组长)单位地址:

泸州市太平街25号

Primary sponsor's address:

25 Taiping Street, Luzhou City

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

四川

市(区县):

泸州

Country:

China

Province:

Sichuan

City:

单位(医院):

西南医科大学附属医院

具体地址:

泸州市太平街25号

Institution
hospital:

Southwest Medical University Affiliated Hospital

Address:

25 Taiping Street, Luzhou City

经费或物资来源:

Source(s) of funding:

None

Target disease:

Trigeminal neuralgia

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

探讨经球囊压迫术治疗三叉神经痛患者的疗效及复发的相关因素  

Objectives of Study:

To investigate the efficacy of balloon compression in the treatment of trigeminal neuralgia and the related factors of recurrence

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

①符合三叉神经痛诊断; ②曾进行球囊压迫术治疗的患者。

Inclusion criteria

① Consistent with the diagnosis of trigeminal neuralgia; ② Had been treated with balloon compression.

排除标准:

①合并严重心系统性疾病患者; ②伴有精神障碍疾病; ③出院后接受过其他手术方案治疗; ④失访,资料不全。

Exclusion criteria:

① patients with severe cardiovascular diseases; ② with mental disorders; ③ received other surgical treatment after discharge; ④ Loss of follow-up and incomplete data.

研究实施时间:

Study execute time:

From 2024-09-30 00:00:00 To 2025-09-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-10-30 00:00:00 To 2025-08-30 00:00:00  

干预措施:

Interventions:

组别:

球囊减压术治疗组

样本量:

60

Group:

Balloon decompression group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

组别:

自身对照组

样本量:

60

Group:

Self control group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China 

Province:

Sichuan 

City:

 

单位(医院):

西南医科大学附属医院 

单位级别:

三甲 

Institution
hospital:

Affiliated Hospital of Southwest Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

术后疼痛BNI分级

指标类型:

主要指标

Outcome:

Postoperative pain was graded by BNI

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后面部麻木程度

指标类型:

副作用指标

Outcome:

Degree of postoperative facial numbness

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术侧咀嚼肌力度减退程度

指标类型:

副作用指标

Outcome:

The decrease of masticatory muscle strength on the operative side

Type:

Adverse events

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

高血压

指标类型:

次要指标

Outcome:

hypertension

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血糖

指标类型:

次要指标

Outcome:

Blood glucose

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

体重指数

指标类型:

次要指标

Outcome:

Body Mass Index

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 40 years
最大 Max age 85 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

None

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表,电子采集和管理系统

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form, Electronic Data Capture(EDC)

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2024-10-21 08:53:17